Christopher Anderson, a Managing Director with StoneTurn, provides financial and economic consulting services to clients and counsel on commercial damages disputes, business valuations, licensing negotiations, and accounting and financial investigations.
Chris has assisted clients on engagements involving patent infringement, misappropriation of trade secrets, securities and breach of contract. He has also participated in large financial accounting investigations and general litigation matters.
Chris has experience in a wide range of industries, including healthcare, pharmaceutical, energy and financial services.
Prior to joining StoneTurn, Chris helped a top-ranked academic medical center analyze the financial, operational and clinical impacts of new medical technologies. Previously, he spent two years with an international consulting firm, where he focused on medical device intellectual property infringement. In addition to his financial and economics experience, Chris also served as a clinical monitor and a study coordinator for Phase I and II clinical trials for contract research organizations. He also worked as a business analyst for an international oilfield equipment manufacturer.
Chris is a Certified Valuation Analyst, a Certified Management Accountant and a Certified Financial Manager.